Mr. Neels has served as a member of our Board of Directors since August 2015. He has been an operating partner of EW Healthcare Partners L.P. (“EW”) since February 2013. Mr. Neels joined EW as a Partner in August 2006, was promoted to Managing Director in 2008 and served in that position until being appointed to Operating Partner. From May 2004 until retiring in November 2005, Mr. Neels served as Chief Operating Officer of Guidant Corporation (“Guidant”), a world leader in the development of cardiovascular medical products, where he was responsible for the global operations of Guidant’s four operating units—Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions. From December 2002 to May 2004, Mr. Neels was Group Chairman, Office of the President at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. From January 2000 to December 2002, Mr. Neels was President of Guidant for Europe, Middle East, Africa and Canada. Mr. Neels previously served as Vice President of Global Marketing for Vascular Intervention and as Managing Director for German and Central European operations. From 1982 to 1994, until Guidant was spun off as an independent public company from Eli Lilly and Co., Mr. Neels held general management, sales and marketing positions at Eli Lilly in the United States and Europe. From 1972 to 1980, he held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the United States. Mr. Neels currently serves on the board of directors of Bioventus LLC, portfolio company of EW Healthcare Partners, and Enercon Technologies. In addition, Mr. Neels also serves on the board of directors of Amici Lovanienses, a not-for-profit organization, and Impulse Dynamics, a privately held corporation. Mr. Neels holds an M.B.A. from Stanford University and a business engineering degree from the University of Leuven in Belgium. Mr. Neels’ qualifications to serve on our Board of Directors include his extensive leadership experience in the medical device and biotechnology industries and his expertise in the commercialization of medical devices, corporate governance and the financial markets.
What is Guido J. Neels' net worth?
The estimated net worth of Guido J. Neels is at least $748,118.64 as of August 16th, 2023. Neels owns 68,259 shares of AxoGen stock worth more than $748,119 as of May 28th. This net worth estimate does not reflect any other investments that Neels may own. Learn More about Guido J. Neels' net worth.
How do I contact Guido J. Neels?
The corporate mailing address for Neels and other AxoGen executives is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. AxoGen can also be reached via phone at (386) 462-6800 and via email at investorrelations@axogeninc.com. Learn More on Guido J. Neels' contact information.
Has Guido J. Neels been buying or selling shares of AxoGen?
Guido J. Neels has not been actively trading shares of AxoGen during the last quarter. Most recently, on Wednesday, August 16th, Guido J. Neels bought 10,000 shares of AxoGen stock. The stock was acquired at an average cost of $6.11 per share, with a total value of $61,100.00. Following the completion of the transaction, the director now directly owns 68,259 shares of the company's stock, valued at $417,062.49. Learn More on Guido J. Neels' trading history.
Who are AxoGen's active insiders?
Are insiders buying or selling shares of AxoGen?
In the last twelve months, insiders at the medical equipment provider sold shares 3 times. They sold a total of 40,173 shares worth more than $589,236.90. The most recent insider tranaction occured on May, 22nd when Director Joseph A Tyndall sold 20,062 shares worth more than $224,694.40. Insiders at AxoGen own 2.8% of the company.
Learn More about insider trades at AxoGen. Information on this page was last updated on 5/22/2025.
